Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03810235 · ClinicalTrials.gov registry record · Phase 4
The OBstetric Lidocaine Patch (OBLido) Trial
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 66
- Enrollment target
NCT03810235 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 66 participants.
The verdict
NCT03810235, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 66 participants
- Enrollment target
Study Summary
This study will be a single-center, single blind, randomized controlled trial. The study will be conducted at UnityPoint-Health Meriter Hospital under investigators from the University of Wisconsin-Madison. Obstetric patients with prepregnancy obesity undergoing a Cesarean delivery at UnityPoint-Health Meriter will be eligible.
Interventions
- DRUG Transdermal Lidocaine Patch
- DRUG Transdermal Hydrocolloid Placebo Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2019-02-15 |
| Est. Completion | 2019-11-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03810235
The ClinicalTrials.gov registry entry for NCT03810235 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transdermal Lidocaine Patch is the first listed.
NCT03810235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03810235 about?
NCT03810235 is a clinical study titled "The OBstetric Lidocaine Patch (OBLido) Trial". This study will be a single-center, single blind, randomized controlled trial. The study will be conducted at UnityPoint-Health Meriter Hospital under investigators from the University of Wisconsin-Madison. Obstetric patients with prepregnancy obesity undergoing a Cesarean delivery at UnityPoint-Hea...
What is the current status of trial NCT03810235?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 66 participants. The study started on 2019-02-15. Estimated completion is 2019-11-30.
What interventions are being tested in trial NCT03810235?
The interventions under investigation include: Transdermal Lidocaine Patch (DRUG), Transdermal Hydrocolloid Placebo Patch (DRUG).
Who is sponsoring clinical trial NCT03810235?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.